Danaher Co. (NYSE:DHR) – Research analysts at Jefferies Group decreased their Q1 2018 earnings per share estimates for shares of Danaher in a report issued on Thursday. Jefferies Group analyst B. Couillard now forecasts that the conglomerate will post earnings per share of $0.91 for the quarter, down from their previous forecast of $1.01. Jefferies Group also issued estimates for Danaher’s Q2 2018 earnings at $1.09 EPS and Q4 2018 earnings at $1.30 EPS.

A number of other equities analysts have also recently commented on DHR. J P Morgan Chase & Co reaffirmed an “overweight” rating and issued a $95.00 price target on shares of Danaher in a research note on Friday, September 8th. Goldman Sachs Group reaffirmed a “neutral” rating and issued a $83.00 price target on shares of Danaher in a research note on Tuesday, September 26th. Cowen reaffirmed a “buy” rating and issued a $90.00 price target on shares of Danaher in a research note on Wednesday, October 4th. Zacks Investment Research raised Danaher from a “hold” rating to a “buy” rating and set a $97.00 price target on the stock in a research note on Thursday, October 5th. Finally, Morgan Stanley reissued an “overweight” rating and set a $95.00 target price (up from $86.00) on shares of Danaher in a research note on Friday, October 6th. One research analyst has rated the stock with a sell rating, six have given a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $94.38.

Shares of Danaher (NYSE:DHR) traded up $0.02 during trading on Monday, reaching $94.38. The company’s stock had a trading volume of 1,878,300 shares, compared to its average volume of 2,625,306. The company has a quick ratio of 1.00, a current ratio of 1.43 and a debt-to-equity ratio of 0.42. The stock has a market cap of $65,650.00, a PE ratio of 24.26, a P/E/G ratio of 2.23 and a beta of 1.02. Danaher has a 1-year low of $77.66 and a 1-year high of $94.84.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.95 by $0.05. The company had revenue of $4.53 billion for the quarter, compared to analysts’ expectations of $4.47 billion. Danaher had a return on equity of 11.29% and a net margin of 13.36%. Danaher’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period last year, the firm posted $0.87 EPS.

The business also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be issued a $0.14 dividend. This represents a $0.56 annualized dividend and a yield of 0.59%. The ex-dividend date of this dividend is Thursday, December 28th. Danaher’s dividend payout ratio (DPR) is 16.67%.

In other news, Director Donald J. Ehrlich sold 10,578 shares of the business’s stock in a transaction on Tuesday, October 24th. The stock was sold at an average price of $90.82, for a total value of $960,693.96. Following the completion of the transaction, the director now owns 104,621 shares in the company, valued at $9,501,679.22. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Daniel Raskas sold 37,870 shares of the business’s stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $93.33, for a total value of $3,534,407.10. The disclosure for this sale can be found here. Insiders sold 273,810 shares of company stock worth $25,218,813 over the last three months. Corporate insiders own 12.20% of the company’s stock.

A number of institutional investors have recently bought and sold shares of the stock. Parametric Portfolio Associates LLC increased its position in Danaher by 6.2% during the third quarter. Parametric Portfolio Associates LLC now owns 1,612,412 shares of the conglomerate’s stock valued at $138,313,000 after acquiring an additional 94,344 shares during the last quarter. AXA increased its position in Danaher by 1.9% in the third quarter. AXA now owns 906,949 shares of the conglomerate’s stock worth $77,798,000 after buying an additional 16,565 shares in the last quarter. Shelton Capital Management increased its position in Danaher by 13.9% in the third quarter. Shelton Capital Management now owns 9,666 shares of the conglomerate’s stock worth $829,000 after buying an additional 1,181 shares in the last quarter. Chicago Partners Investment Group LLC increased its position in Danaher by 394.1% in the third quarter. Chicago Partners Investment Group LLC now owns 3,953 shares of the conglomerate’s stock worth $339,000 after buying an additional 3,153 shares in the last quarter. Finally, Steward Partners Investment Advisory LLC purchased a new stake in Danaher in the third quarter worth about $389,000. Institutional investors own 76.05% of the company’s stock.

WARNING: “Danaher Co. (DHR) Expected to Post Q1 2018 Earnings of $0.91 Per Share” was published by Watch List News and is owned by of Watch List News. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The original version of this news story can be accessed at https://www.watchlistnews.com/danaher-co-dhr-expected-to-post-q1-2018-earnings-of-0-91-per-share/1774796.html.

Danaher Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Earnings History and Estimates for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.